Adeleke M Badejo Jr
Overview
Explore the profile of Adeleke M Badejo Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Murthy S, Pankey E, Banka A, Badejo Jr A, Wekerle R, Vilija V, et al.
J Diabetes Complications
. 2012 Jul;
26(6):470-5.
PMID: 22770941
Objective: We compared the effect of the long acting basal insulin analog detemir with neutral protamine Hagedorn (NPH) insulin, and normal saline on recovery from vascular injury (balloon catheter mediated)...
2.
Pankey E, Bhartiya M, Badejo Jr A, Haider U, Stasch J, Murthy S, et al.
Am J Physiol Heart Circ Physiol
. 2011 Jan;
300(3):H792-802.
PMID: 21217076
4-({(4-Carboxybutyl)[2-(5-fluoro-2-{[4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]amino}methyl)benzoic acid (BAY 60-2770) is a nitric oxide (NO)-independent activator of soluble guanylyl cyclase (sGC) that increases the catalytic activity of the heme-oxidized or heme-free form of the enzyme. In...
3.
Lasker G, Matt C, Badejo Jr A, Casey D, Dhaliwal J, Murthy S, et al.
Can J Physiol Pharmacol
. 2010 Jul;
88(7):770-6.
PMID: 20651825
It has been reported that sodium nitrite (NaNO2) can act as a storage form of nitric oxide (NO) that can have beneficial pharmacologic actions. The present study was undertaken to...
4.
Badejo Jr A, Nossaman V, Pankey E, Bhartiya M, Kannadka C, Murthy S, et al.
Am J Physiol Heart Circ Physiol
. 2010 Jul;
299(4):H1153-9.
PMID: 20639220
BAY 41-8543 is a nitric oxide (NO)-independent stimulator of soluble guanylyl cyclase (sGC). Responses to intravenous injections of BAY 41-8543 were investigated under baseline and elevated tone conditions and when...
5.
Badejo Jr A, Hodnette C, Dhaliwal J, Casey D, Pankey E, Murthy S, et al.
Am J Physiol Heart Circ Physiol
. 2010 Jun;
299(3):H819-26.
PMID: 20543077
It has been reported that mitochondrial aldehyde dehydrogenase (ALDH2) catalyzes the formation of glyceryl dinitrate and inorganic nitrite from glyceryl trinitrate (GTN), leading to an increase in cGMP and vasodilation...
6.
Dhaliwal J, Badejo Jr A, Casey D, Murthy S, Kadowitz P
J Pharmacol Exp Ther
. 2009 Apr;
330(1):334-41.
PMID: 19369577
The effects of SB-772077-B [4-(7-((3-amino-1-pyrrolidinyl)carbonyl)-1-ethyl-1H-imidazo(4,5-c)pyridin-2-yl)-1,2,5-oxadiazol-3-amine], an aminofurazan-based Rho kinase inhibitor, on the pulmonary vascular bed and on monocrotaline-induced pulmonary hypertension were investigated in the rat. The intravenous injections of SB-772077-B...
7.
Casey D, Badejo Jr A, Dhaliwal J, Murthy S, Hyman A, Nossaman B, et al.
Am J Physiol Heart Circ Physiol
. 2008 Dec;
296(2):H524-33.
PMID: 19074675
Recent studies show that pulmonary vasodilator responses to nitrite are enhanced by hypoxia. However, the mechanism by which nitrite is converted to vasoactive nitric oxide (NO) is uncertain. In the...
8.
Badejo Jr A, Dhaliwal J, Casey D, Gallen T, Greco A, Kadowitz P
Am J Physiol Lung Cell Mol Physiol
. 2008 Aug;
295(5):L828-36.
PMID: 18689606
The small GTP-binding protein Rho and its downstream effector, Rho-kinase, are important regulators of vasoconstrictor tone. Rho-kinase is upregulated in experimental models of pulmonary hypertension, and Rho-kinase inhibitors decrease pulmonary...
9.
Dhaliwal J, Casey D, Greco A, Badejo Jr A, Gallen T, Murthy S, et al.
Am J Physiol Lung Cell Mol Physiol
. 2007 Sep;
293(5):L1306-13.
PMID: 17766587
The small GTP-binding protein and its downstream effector Rho kinase play an important role in the regulation of vasoconstrictor tone. Rho kinase activation maintains increased pulmonary vascular tone and mediates...